New Brunswick, NJ - According to Katie Eder, "Rutgers team behind new heart treatment. A new Rutgers study may lead to better treatment of systolic heart failure, one of the most common cardiac disorders in which the ability to pump blood becomes restricted and whose risks increase with age. Using a pharmaceutical treatment for systolic heart failure developed by Cytokinetics Inc. that is being tested in clinical trials, new research at Rutgers Robert Wood Johnson Medical School determined the precise interaction between the drug and what researchers call the cardiac "motor."
Trenton, NJ - According to Tome Bergeron, "Macrocure, a clinical-stage biopharmaceutical company based in Israel, appears to be closer to moving its headquarters to New Jersey. The Economic Development Authority awarded Grow NJ tax credits for up to $3.2 million over 10 years for Macrocure to establish its North American headquarters at the EDA’s Technology Centre of New Jersey in North Brunswick. The EDA previously had approved a 10-year, three-month lease at the Centre.
Kenilworth, NJ - Merck, known as MSD outside the United States and Canada, and The University of Texas MD Anderson Cancer Center today announced that they have entered into a strategic clinical research collaboration to evaluate Merck’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), in combination with other treatments, such as chemotherapy, radiation therapy and/or novel antitumor medicines.
New Brunswick, NJ - Sherine E. Gabriel, MD, shares a common bond with the Rutgers Robert Wood Johnson Medical School Class of 2019; she officially joined the school during the first week of August, too. On Friday, Aug. 7, Gabriel, the first female dean at Robert Wood Johnson Medical School, welcomed more than 190 incoming medical students during the annual White Coat Ceremony.
New Brunswick, NJ - Pharmacists have many opportunities for collaborating with nurse practitioners (NPs) and physician assistants (PAs) on managing chronic and acute conditions commonly seen in the retail health practice setting. That was a central theme of the 1st Annual Convenient Healthcare and Pharmacy Collaborative (CHPC), which featured 10 clinical sessions providing continuing education credits for pharmacists, NPs, PAs.
NJEDA August Board Meeting Highlights Array of State Support for Technology and Life Sciences Sector
Trenton, NJ - Continuing the state’s commitment to supporting the growth of the technology and life sciences industries, which are targeted for growth under the Economic Opportunity Act (EOA), the Board of the New Jersey Economic Development Authority (EDA) today took action to approve Grow New Jersey (Grow NJ) tax credits for two Middlesex County projects.
Pemberton, NJ - This fall, Rowan College at Burlington County is starting the first magnetic resonance (MR) credit-based program in New Jersey for technologists who are certified by the American Registry of Radiologic Technologists (ARRT) and want to advance their career by becoming trained in MR.
Trenton, NJ - According to New Jersey Business magazine, "New Jersey pulled out all the stops in attracting the international biotech community at the recent 2015 BIO International Convention in Philadelphia. The event drew 15,858 industry leaders from 69 countries and 47 states, and the New Jersey delegation spent the three-day event in June discussing the many benefits of growing and attracting a business to the Garden State for this global audience."
Immunomedics Announces Orphan Drug Designation for Veltuzumab for the Treatment of Immune Thrombocytopenia
Morris Plains, NJ - Immunomedics, Inc. today announced that the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA) has granted orphan status for the use of veltuzumab, the Company’s humanized anti-CD20 antibody, for the treatment of immune thrombocytopenia (ITP). In a Phase 1 study,1 low-dose veltuzumab, as a single agent, produced an objective response rate of 55 percemt in 38 response-assessable patients with relapsed ITP, including 11 patients (29 percent) who reported a complete response.
NJHF Honors 16 Rutgers Faculty Members with 2015 Excellence in Teaching and Excellence in Research Awards
New Brunswick, NJ - New Jersey Health Foundation honored 19 faculty members from Rutgers Biomedical and Health Sciences and Rowan University School of Osteopathic Medicine with 2015 Excellence in Teaching and Excellence in Research Awards, which were presented at individual school convocations. Each winner, selected by his/her school, received a framed award and an honorarium to be used to advance his/her teaching or research abilities during the course of the coming year.
New Brunswick, NJ - This is to provide information and updates regarding the newly instituted 2015 pilot grants in neuroscience at Rutgers University. This pilot grant program is organized under the Brain Health Institute, as part of its mission to support neuroscience research across the new Rutgers University. There are two main objectives of these pilot awards.
New Brunswick, NJ - A newly formed team of Rutgers faculty, research staff, and administrators began work last month on the Preparation for Research Excellence Program (PREP), a professional development initiative to support early career faculty members. The program was created by team members in response to the Rutgers Strategic Plan Initiative. Their proposal earned a one-year grant from Rutgers–New Brunswick Provost Lily Young.
Jersey City, NJ - According to Eric Strauss of NJBiz, "A North Carolina drug development company is selling off one of its businesses and moving to Jersey City. Scynexis Inc. will relocate from Research Triangle Park effective Aug. 1, it said in a news release, and focus on developing its SCY-078 antifungal drug."
Hoboken, NJ - Biomaterials have increasingly become an integral part of clinical and surgical practice in orthopedics, dentistry, cardiology and soft tissue applications, among others. These technologies include artificial joints, bone grafts, heart valves, dental fillings, and reconstructive tissue.
Trenton, NJ - On the heels of the state’s commanding presence at BIO International 2015, New Jersey’s dominance in biotechnology was validated with a top ranking nationally in the Biotech Growth Potential category in Business Facilities Magazine’s Annual Rankings Report released today.
Do not miss a single innovative moment and sign up for our newsletter!